| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Research Abstract |
We showed that the strong induction of SERCA2 expression in the epidermal keratinocytes after the treatments with cannabinoid and vanilloid agonists are direct effects through CB2 and TRPV3/4 receptor, respectively. Also the external application on the Darier's and psoriatic model mouse as a representative of hereditary and inflammatory keratosis, we found that especially the cannabinoids brought about the significant pathological effects which include the a recovery of a stratum granulosum, while vanniloid did not bring such strong impact. I believe that the cannabinoids agonist can be a good candidate of the future therapeutic drug against the hyperkeratotic skin diseases.
|
